Nisa Investment Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Sell
775
-425
-35% -$10.3K ﹤0.01% 2265
2026
Q1
$28.8K Buy
+1,200
New +$31.3K ﹤0.01% 1886
2025
Q4
Sell
-27
Closed -$269 3007
2025
Q3
$269 Hold
27
﹤0.01% 2926
2025
Q2
$245 Sell
27
-38
-58% -$361 ﹤0.01% 2970
2025
Q1
$620 Buy
+65
New +$788 ﹤0.01% 2756
2022
Q2
Sell
-7,200
Closed -$141K 2420
2022
Q1
$141K Buy
+7,200
New +$146K ﹤0.01% 1505

Other funds holding GLSI

Nisa Investment Advisors's GLSI Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Greenwich LifeSciences (GLSI) stake by 35% in Q2 2026, selling an estimated $10.3K and leaving 775 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2265.

Nisa Investment Advisors first reported a position in GLSI in Q1 2022 and has held it in 6 quarters since. The position peaked at $141K in Q1 2022. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Nisa Investment Advisors held 775 shares of Greenwich LifeSciences worth $18.2K as of Q2 2026.
  • Nisa Investment Advisors sold 425 Greenwich LifeSciences shares in Q2 2026, an estimated $10.3K.
  • Greenwich LifeSciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2265 holding.
  • Nisa Investment Advisors first reported a position in Greenwich LifeSciences in Q1 2022 and has held it in 6 quarters since.
  • Nisa Investment Advisors's Greenwich LifeSciences position peaked at $141K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.